Nov 16 (Reuters) - Prometic Life Sciences Inc PLI.TO
* Says phase 2 clinical trial on pbi-4050 expected to commence in Q4 2016
* Prometic receives clearance from Health Canada to proceed with its PBI-4050 placebo-controlled phase 2 clinical trial in patients with metabolic syndrome and type 2 diabetes Source text for Eikon: ID:nCNWR0c2Ca Further company coverage: PLI.TO